BioNTech SE (BSP:B1NT34) Buildings And Improvements : R$1,121 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is BioNTech SE Buildings And Improvements?

BioNTech SE's quarterly buildings and improvements stayed the same from Jun. 2023 (R$0 Mil) to Sep. 2023 (R$0 Mil) but then increased from Sep. 2023 (R$0 Mil) to Dec. 2023 (R$1,121 Mil).

BioNTech SE's annual buildings and improvements increased from Dec. 2021 (R$1,118 Mil) to Dec. 2022 (R$1,147 Mil) but then declined from Dec. 2022 (R$1,147 Mil) to Dec. 2023 (R$1,121 Mil).

BioNTech SE Buildings And Improvements Historical Data

The historical data trend for BioNTech SE's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Buildings And Improvements Chart

BioNTech SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

250.63

506.33

1,118.20

1,147.43

1,121.02

BioNTech SE Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Buildings And Improvements	Get a 7-Day Free Trial															1,147.43	-	-	-	1,121.02

BioNTech SE Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

BioNTech SE (BSP:B1NT34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (BSP:B1NT34) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

BNTX:USA BNTX:Mexico 0A3M:UK 22UA:Germany BNTX:Austria

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.

BioNTech SE (BSP:B1NT34) Headlines

No Headlines